AGR.L

Assura Plc
Assura plc - Notice of Dividend
3rd December 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4666O
Assura PLC
03 December 2024
 

 

3 December 2024

Assura plc

 

Notice of Dividend

 

Assura plc ("Assura" or "the Company"), UK's leading diversified healthcare REIT, today announces that the next quarterly interim dividend of 0.84 pence per share will be paid on 15 January 2025 to shareholders on the register on 13 December 2024 (the "Record Date"). The Ex-dividend Date will be 12 December 2024.

 

This interim dividend will be a normal dividend (non-PID). Please refer to Company's website HERE for more information.

 

Please note that there is no Scrip Dividend Alternative available for this quarterly dividend and will be paid in full as cash.

 

For future dividend payments, including this one, CREST holders will automatically receive their dividend via CREST unless they have specifically opted out.

 

Key dates:

 

Ex-dividend date: 12 December 2024

Record date: 13 December 2024

Dividend payment date: 15 January 2025

 

A separate announcement with additional information concerning shares held on the Johannesburg Stock Exchange has been published via the SENS system.

 

- Ends -

 

For more information, please contact:

 

Assura plc
 David Purcell, Investor Relations Director

Tel: 0161 515 2043
 Email: Investor@assura.co.uk

 

FGS Global

Gordon Simpson
Grace Whelan

 

Tel: 0207 251 3801
 Email: Assura@fgsglobal.com

 

Notes to Editors

Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

 

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices and has a secondary listing on the Johannesburg Stock Exchange. As at 30 September 2024, Assura's portfolio was valued at £3.2 billion and has a strong track record of growing financial returns and dividends for shareholders.

 

At Assura we BUILD for health and as the first FTSE 250 certified B Corp we are committed to keeping ESG at the heart of our strategy, creating Healthy Environments (E) and Healthy Communities (S) and maintaining a Healthy Business (G).

 

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVUPGBPPUPCGCP]]>
TwitterFacebookLinkedIn